Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFrom 1 September 2025, Eli Lilly raised Mounjaro's UK list price significantly — the highest-dose pen moved from around £122 to around £330. That shift rippled through private providers, and typical private prices since then range roughly £149 to £375 per month depending on dose and pharmacy. Mounjaro is a prescription-only medicine, which means the price you see should always reflect a clinical assessment, not just the cost of the pen itself. The question most people are really weighing up isn't whether the price went up (it did) but whether the service behind any given price is worth what you're paying.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Eli Lilly's decision to increase the UK list price for Mounjaro from September 2025 was widely reported, and the effect on private prescriptions was immediate. The lower doses saw more modest increases; the 15mg pen saw the sharpest rise. Private providers set their own prices above the list price to cover dispensing, clinical oversight and delivery, so the gap between doses narrowed in some cases but didn't disappear.
What the price change didn't alter is the medicine itself, the clinical pathway that a legitimate provider must follow, or the supply chain it should come from. Mounjaro is manufactured by Eli Lilly and dispensed through the licensed UK supply chain. A price shift from the manufacturer changes the floor, not the structure of what a compliant service looks like.
If you want the full picture of how prices have moved across doses, the history of Mounjaro price changes in the UK sets out each adjustment in context. For 2026 specifically, what's happening with the Mounjaro price in 2026 is worth reading before you decide anything.
A listed monthly price for a prescription medicine rarely tells the whole story. Some providers charge separately for the initial consultation. Others add a prescription fee on top, or quote a dispensing-only figure that doesn't include clinical review, dose support or aftercare. Delivery (which matters for a temperature-sensitive injectable) can be an additional charge, and repeat-order reviews are sometimes treated as optional extras.
Add those up and the gap between a low headline and a higher all-in price often closes, sometimes completely. The MHRA and NHS have both been clear that these are prescription-only medicines requiring clinical assessment before supply; the NHS tirzepatide medicines page confirms that Mounjaro should only be used under medical supervision. A price that skips that step isn't a deal, it's a gap in the service.
It's also worth knowing that what Mounjaro actually costs through a private pharmacy depends on dose, and the 5mg dose in particular has its own pricing profile, the cost of 5mg Mounjaro is a reasonable starting point if you're early in treatment.
We don't price-match. Cheapest isn't a race we entered, and that's deliberate. At nume, one price covers everything: consultation, prescription, the medicine, and free next-working-day delivery by DPD. Your pen arrives tracked, in a plain box, ready to go straight in the fridge. There is no subscription, no auto-renewal and no hidden fee waiting at checkout. Every repeat order gets its own clinical review, a real prescriber reads your update, not software.
Our GPhC-registered pharmacy (registration number 9012878, verifiable at the GPhC register) sources Mounjaro through the licensed UK supply chain via Eli Lilly's authorised network. The prescribers on our clinical team, including our lead prescriber, review consultations personally and the same day. Current treatment pricing is shown on the treatment page, we don't print per-pen figures in article copy because the right dose for you is a clinical question, not a menu choice.
After a significant price rise, it's natural to shop around. For most purchases, finding the lowest price is straightforwardly sensible. For a prescription-only injectable medicine, the lowest price can mean the clinical layer has been skimped on, or worse, that what's being sold didn't come from the licensed supply chain at all.
The MHRA has warned publicly about counterfeit weight-loss pens sold online, including fake tirzepatide pens seized in the UK as recently as late 2025. Around 20 million doses of illegally traded weight-loss medicines (roughly £45m street value) were seized in 2025 alone. The MHRA's Yellow Card scheme lets you report suspect sellers directly. Red flags include sellers who offer Mounjaro without requiring a prescription, prices far below the current market range, and if you're comparing providers, our guide to finding the cheapest chemist for Mounjaro explains what to look for and what to be cautious about. It's also useful to understand why the Mounjaro price went up before drawing conclusions about what any given figure actually reflects.
A small saving on a single pen isn't the measure that keeps you safe on treatment. The right questions are: is there a real prescriber involved, is the pharmacy GPhC-registered, and does the supply chain trace back to Eli Lilly? If you'd like to explore whether Mounjaro is clinically appropriate for you, our weight-loss treatment overview is a good place to start, or go straight to your free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.